a p p e n d i x1 l i s t o f s o l v e n t s i n c l u d e d i n t h e g u i d a n c e（我x1 p p e n d l l i s t o f s o v e n t s i n c u l d e d n t h e g u我d n c e）.docVIP

下载本文档

208
0
约1.14万字
约 10页
2017-01-18 发布于湖南
举报

a p p e n d i x1 l i s t o f s o l v e n t s i n c l u d e d i n t h e g u i d a n c e（我x1 p p e n d l l i s t o f s o v e n t s i n c u l d e d n t h e g u我d n c e）.doc

a p p e n d i x1 l i s t o f s o l v e n t s i n c l u d e d i n t h e g u i d a n c e（我x1 p p e n d l l i s t o f s o v e n t s i n c u l d e d n t h e g u我d n c e）

Guidance for Industry Q3C — Tables and List U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) November 2003 ICH Revision 1 Guidance for Industry Q3C — Tables and List Additional copies are available from: Center for Drug Evaluation and Research (CDER) Division of Drug Information (HFD-240) Food and Drug Administration 5600 Fishers Lane Rockville, MD 20857 (Tel) 301-827-4573 /cder/guidance/index.htm or Office of Com

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

a p p e n d i x1 l i s t o f s o l v e n t s i n c l u d e d i n t h e g u i d a n c e（我x1 p p e n d l l i s t o f s o v e n t s i n c u l d e d n t h e g u我d n c e）.docVIP